Tonsilla compositum
Tonsilla compositum oral vial
FULL PRESCRIBING INFORMATION: CONTENTS*
- TONSILLA COMPOSITUM DESCRIPTION
- INDICATION AND USAGE
- TONSILLA COMPOSITUM DOSAGE AND ADMINISTRATION
- TONSILLA COMPOSITUM CONTRAINDICATIONS
- WARNINGS AND PRECAUTIONS
- TONSILLA COMPOSITUM ADVERSE REACTIONS
- OVERDOSAGE
- CLINICAL PHARMACOLOGY
- DOSAGE
FULL PRESCRIBING INFORMATION
TONSILLA COMPOSITUM DESCRIPTION
Each 2.2 ml ampule contains:
|
Ingredient Name |
Potency |
Quantity |
|
Conium maculatum |
4x |
22µ |
|
Dulcamara |
4x |
22µ |
|
Echinacea |
4x |
22µ |
|
Aesculus hippocastanum |
6x |
22µ |
|
Antimonium tartaricum |
10x |
22µ |
|
Ascorbicum acidum |
6x |
22µ |
|
Coccus cacti |
4x |
22µ |
|
Galium aparine |
6x |
22µ |
|
Gentiana lutea |
8x |
22µ |
|
Geranium robertianum |
6x |
22µ |
|
Pulsatilla |
8x |
22µ |
|
Sarcolacticum acidum |
6x |
22µ |
|
Glandula lymphatica |
8x |
22µ |
|
Sulphur |
8x |
22µ |
|
Calcarea phosphorica |
10x |
22µ |
|
Ferrum phosphoricum |
10x |
22µ |
|
Funiculus umbilicalis suis |
10x |
22µ |
|
Hepar suis |
10x |
22µ |
|
Hypothalamus suis |
10x |
22µ |
|
Medulla ossis suis |
10x |
22µ |
|
Splen suis |
10x |
22µ |
|
Cortisone aceticum |
13x |
22µ |
|
Embryo suis |
13x |
22µ |
|
Mercurius solubilis |
13x |
22µ |
|
Levothyroxinue |
13x |
22µ |
|
Baryta carbonica |
28x |
22µ |
|
Tonsilla suis |
|
|
Inactive Ingredient: Isotonic Sodium Chloride solution
INDICATION AND USAGE
Tonsilla compositum® Oral Vial is a homeopathic drug product indicated for the temporary relief of minor throat, laryngitis and minor throat irritation.
TONSILLA COMPOSITUM DOSAGE AND ADMINISTRATION
Dosage:
Adults and children above 6 years: 1 vial orally 1-3 times daily
Children up to 6 years: ½ vial orally 1-3 times daily
TONSILLA COMPOSITUM CONTRAINDICATIONS
Tonsilla compositum® Oral Vials are contraindicated in patients with known hypersensitivity to Tonsilla compositum® or any of its ingredients.
WARNINGS AND PRECAUTIONS
Warnings and Precautions
None
TONSILLA COMPOSITUM ADVERSE REACTIONS
No adverse events have been reported with a causal relationship Thonsilla compositum® Oral Vials.
OVERDOSAGE
Overdosage: No negative effects of an overdose have been reported and none are expected due to the homeopathic dilutions
CLINICAL PHARMACOLOGY
Mechanism of Action The exact mechanism of Tonsilla compositum® Oral Vials is not fully understood. Pharmacodynamics Not applicable for homeopathic medicinal products.
DOSAGE
1 oral vial containing 2.2ml solution for oral administration
Tonsilla compositumCONIUM MACULATUM FLOWERING TOP, SOLANUM DULCAMARA TOP, ECHINACEA, UNSPECIFIED, HORSE CHESTNUT,ANTIMONY POTASSIUM TARTRATE, ASCORBIC ACID, PROTORTONIA CACTI,GALIUM APARINE,GENTIANA LUTEA ROOT,GERANIUM ROBERTIANUM, PULSATILLA VULGARIS,LACTIC ACID, L-, SUS SCROFA ADRENAL GLAND,SULFUR,TRIBASIC CALCIUM PHOSPHATE,FERROSOFERRIC PHOSPHATE,SUS SCROFA UMBILICAL CORD,PORK LIVER,SUS SCROFA HYPOTHALAMUSSUS SCROFA BONE MARROW,SUS SCROFA SPLEEN,SUS SCROFA ADRENAL GLAND, CORTISONE ACETATE, SUS SCROFA EMBRYO, SOLUTION
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
